FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,988,728 | -54.4% | 4,711,664 | +2.4% | 0.01% | -54.5% |
| Q2 2023 | $21,893,330 | +29.5% | 4,599,439 | +55.1% | 0.02% | +22.2% |
| Q1 2023 | $16,901,880 | +549.5% | 2,965,242 | +1049.7% | 0.02% | +500.0% |
| Q4 2022 | $2,602,443 | +34.2% | 257,923 | +415.8% | 0.00% | +50.0% |
| Q1 2022 | $1,939,000 | +83.6% | 50,000 | +180.6% | 0.00% | +100.0% |
| Q3 2021 | $1,056,000 | -85.4% | 17,821 | -78.7% | 0.00% | -83.3% |
| Q2 2021 | $7,251,000 | -71.3% | 83,548 | -72.7% | 0.01% | -75.0% |
| Q1 2021 | $25,249,000 | -29.9% | 306,238 | -22.7% | 0.02% | -25.0% |
| Q4 2020 | $36,022,000 | +71.2% | 396,157 | -24.7% | 0.03% | +45.5% |
| Q3 2020 | $21,037,000 | +36.0% | 526,327 | +16.7% | 0.02% | +22.2% |
| Q2 2020 | $15,472,000 | +65.4% | 450,960 | +7.1% | 0.02% | +20.0% |
| Q1 2020 | $9,355,000 | +350.0% | 421,201 | +296.4% | 0.02% | +650.0% |
| Q4 2019 | $2,079,000 | +670.0% | 106,252 | +697.6% | 0.00% | – |
| Q2 2019 | $270,000 | -24.8% | 13,322 | -63.8% | 0.00% | – |
| Q1 2018 | $359,000 | – | 36,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |